{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:17:36Z","timestamp":1790641056401,"version":"4.1.0"},"reference-count":83,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 15403"],"award-info":[{"award-number":["IG 15403"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2017A5TXC3"],"award-info":[{"award-number":["2017A5TXC3"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["800924"],"award-info":[{"award-number":["800924"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Glutathione (GSH) is the predominant low-molecular-weight antioxidant with a ubiquitous distribution inside the cell. The steady-state level of cellular GSH is dependent on the balance between synthesis, hydrolysis, recycling of glutathione disulphide (GSSG) as well as cellular extrusion of reduced, oxidized, or conjugated-forms. The augmented oxidative stress typical of cancer cells is accompanied by an increase of glutathione levels that confers them growth advantage and resistance to a number of chemotherapeutic agents. Targeting glutathione metabolism has been widely investigated for cancer treatment although GSH depletion as single therapeutic strategy has resulted largely ineffective if compared with combinatorial approaches. In this review, we circumstantiate the role of glutathione in tumour development and progression focusing on how interfering with different steps of glutathione metabolism can be exploited for therapeutic purposes. A dedicated section on synthetic lethal interactions with GSH modulators will highlight the promising option of harnessing glutathione metabolism for patient-directed therapy in cancer.<\/jats:p>","DOI":"10.3390\/nu11081926","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T06:10:14Z","timestamp":1566195014000},"page":"1926","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy"],"prefix":"10.3390","volume":"11","author":[{"given":"Enrico","family":"Desideri","sequence":"first","affiliation":[{"name":"Department of Biology, University of Rome \u201cTor Vergata\u201d, Via della Ricerca Scientifica, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciccarone","sequence":"additional","affiliation":[{"name":"IRCCS San Raffaele Pisana, Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Ciriolo","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome \u201cTor Vergata\u201d, Via della Ricerca Scientifica, 00133 Rome, Italy"},{"name":"IRCCS San Raffaele Pisana, Via della Pisana 235, 00163 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fphar.2014.00196","article-title":"Glutathione: New roles in redox signaling for an old antioxidant","volume":"5","author":"Aquilano","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.redox.2015.07.008","article-title":"Antioxidant responses and cellular adjustments to oxidative stress","volume":"6","author":"Miguel","year":"2015","journal-title":"Redox Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jn\/134.3.489","article-title":"Glutathione metabolism and its implications for health","volume":"134","author":"Wu","year":"2004","journal-title":"J. Nutr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/biof.1476","article-title":"Glutathione compartmentalization and its role in glutathionylation and other regulatory processes of cellular pathways","volume":"45","author":"Cianfruglia","year":"2019","journal-title":"BioFactors Oxf. Engl."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1074\/jbc.R111.287995","article-title":"Redox outside the box: Linking extracellular redox remodeling with intracellular redox metabolism","volume":"287","author":"Banerjee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1089\/ars.2012.4599","article-title":"Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: From cofactors to antioxidants to redox signaling","volume":"19","author":"Hanschmann","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/13813455.2014.944544","article-title":"Protein S-glutathionylation: From current basics to targeted modifications","volume":"120","author":"Popov","year":"2014","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"15857","DOI":"10.1074\/jbc.274.22.15857","article-title":"Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation","volume":"274","author":"Klatt","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","article-title":"Glutathione synthesis","volume":"1830","author":"Lu","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0076-6879(02)47021-8","article-title":"In vivo antioxidant role of glutathione peroxidase: Evidence from knockout mice","volume":"347","author":"Lei","year":"2002","journal-title":"Methods Enzymol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/abbi.1994.1444","article-title":"The reaction of superoxide with reduced glutathione","volume":"314","author":"Winterbourn","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/BF02544533","article-title":"Reduced glutathione effects on alpha-tocopherol concentration of rat liver microsomes undergoing NADPH-dependent lipid peroxidation","volume":"24","author":"Graham","year":"1989","journal-title":"Lipids"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.bbagen.2012.11.019","article-title":"Glutathione transferases, regulators of cellular metabolism and physiology","volume":"1830","author":"Board","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mam.2008.08.004","article-title":"Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology","volume":"30","author":"Ballatori","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tips.2006.06.008","article-title":"Transport of glutathione and glutathione conjugates by MRP1","volume":"27","author":"Cole","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1089\/ars.2012.4553","article-title":"Glutathione efflux and cell death","volume":"17","author":"Franco","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/B978-0-12-420117-0.00003-7","article-title":"Gamma-glutamyl transpeptidase: Redox regulation and drug resistance","volume":"122","author":"Hanigan","year":"2014","journal-title":"Adv. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/iub.1756","article-title":"The glutathione cycle: Glutathione metabolism beyond the \u03b3-glutamyl cycle","volume":"70","author":"Bachhawat","year":"2018","journal-title":"IUBMB Life"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/ars.2011.4391","article-title":"The Cystine\/Glutamate Antiporter System xc\u2212 in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities","volume":"18","author":"Lewerenz","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15878","DOI":"10.1074\/jbc.M114.635144","article-title":"Human CHAC1 Protein Degrades Glutathione, and mRNA Induction Is Regulated by the Transcription Factors ATF4 and ATF3 and a Bipartite ATF\/CRE Regulatory Element","volume":"290","author":"Crawford","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1074\/jbc.M116.727479","article-title":"ChaC2, an Enzyme for Slow Turnover of Cytosolic Glutathione","volume":"292","author":"Kaur","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2017.01.004","article-title":"Reactive oxygen species and cancer paradox: To promote or to suppress?","volume":"104","author":"Galadari","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6050123","DOI":"10.1155\/2019\/6050123","article-title":"Oxidative Stress-Driven Autophagy acROSs Onset and Therapeutic Outcome in Hepatocellular Carcinoma","volume":"2019","author":"Ciccarone","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/carcin\/bgp203","article-title":"Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway","volume":"31","author":"Choi","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.18632\/oncotarget.1940","article-title":"ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail","volume":"5","author":"Cichon","year":"2014","journal-title":"Oncotarget"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"38832","DOI":"10.1074\/jbc.M110.124958","article-title":"Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1","volume":"285","author":"Luanpitpong","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ncb3341","article-title":"Glutathione biosynthesis is a metabolic vulnerability in PI(3)K\/Akt-driven breast cancer","volume":"18","author":"Lien","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm.4407","article-title":"Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis","volume":"23","author":"Romero","year":"2017","journal-title":"Nat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"E4600","DOI":"10.1073\/pnas.1513433112","article-title":"Chemotherapy triggers HIF-1\u2013dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype","volume":"112","author":"Lu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13578-015-0049-3","article-title":"A review on hepatocyte nuclear factor-1beta and tumor","volume":"5","author":"Yu","year":"2015","journal-title":"Cell Biosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1007\/s13277-015-4290-5","article-title":"HNF1\u03b2 drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC)","volume":"37","author":"Nunes","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature13557","article-title":"Fructose-1, 6-bisphosphatase opposes renal carcinoma progression","volume":"513","author":"Li","year":"2014","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance","volume":"217","author":"Bansal","year":"2018","journal-title":"J. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression","volume":"27","author":"Harris","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mc.21923","article-title":"A functional trinucleotide repeat polymorphism in the 5\u2019-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers","volume":"52","author":"Nichenametla","year":"2013","journal-title":"Mol. Carcinog."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1245\/s10434-015-4431-5","article-title":"Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette-Guerin Instillation for Non-muscle Invasive Bladder Cancer","volume":"22","author":"Ke","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/annonc\/mdq212","article-title":"Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients","volume":"21","author":"Sun","year":"2010","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_38","first-page":"1169","article-title":"Gamma-glutamyltransferase of Cancer Cells at the Crossroads of Tumor Progression, Drug Resistance and Drug Targeting","volume":"30","author":"Corti","year":"2010","journal-title":"Anticancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e2848","DOI":"10.1038\/cddis.2017.225","article-title":"Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death","volume":"8","author":"Cheteh","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","article-title":"Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"ref_41","first-page":"671","article-title":"Glutathione levels in human tumors","volume":"17","author":"Gamcsik","year":"2012","journal-title":"Biomark. Biochem. Indic. Expo. Response Susceptibility Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.cmet.2019.01.020","article-title":"Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion","volume":"29","author":"Harris","year":"2019","journal-title":"Cell Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e1505","DOI":"10.1038\/cddis.2014.465","article-title":"Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo","volume":"5","author":"Rocha","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1158\/1078-0432.CCR-11-0736","article-title":"Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism","volume":"17","author":"Fath","year":"2011","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1096\/fj.201701157R","article-title":"Modulation of glutathione promotes apoptosis in triple-negative breast cancer cells","volume":"32","author":"Miran","year":"2018","journal-title":"FASEB J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","article-title":"Broad targeting of resistance to apoptosis in cancer","volume":"35","author":"Mohammad","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1038\/bcj.2014.45","article-title":"The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma","volume":"4","author":"Tagde","year":"2014","journal-title":"Blood Cancer J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/pbc.25994","article-title":"A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent\/Refractory High-Risk Neuroblastoma","volume":"63","author":"Villablanca","year":"2016","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1200\/JCO.1994.12.1.194","article-title":"Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: An attempt at modulation of glutathione","volume":"12","author":"Bailey","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1124\/mol.106.024778","article-title":"Structure-based identification of novel human gamma-glutamylcysteine synthetase inhibitors","volume":"71","author":"Hamilton","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Robe, P.A., Martin, D.H., Nguyen-Khac, M.T., Artesi, M., Deprez, M., Albert, A., Vanbelle, S., Califice, S., Bredel, M., and Bours, V. (2009). Early termination of ISRCTN45828668, a phase 1\/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-372"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/jcb.27456","article-title":"Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5","volume":"120","author":"Lee","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_54","first-page":"3001","article-title":"Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4-mediated ferroptosis","volume":"17","author":"Pan","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157340811796575308","article-title":"Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Strategy to Augment Antioxidant Defense","volume":"7","author":"Hiratake","year":"2011","journal-title":"Curr. Enzyme Inhib."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.freeradbiomed.2016.02.028","article-title":"The role of glutathione reductase and related enzymes on cellular redox homoeostasis network","volume":"95","author":"Couto","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.freeradbiomed.2009.04.022","article-title":"Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation","volume":"47","author":"Zhao","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"30102","DOI":"10.18632\/oncotarget.4945","article-title":"Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death","volume":"6","author":"Catanzaro","year":"2015","journal-title":"Oncotarget"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"17021","DOI":"10.1200\/jco.2006.24.18_suppl.17021","article-title":"NOV-002, a chemoprotectant\/immunomodulator, added to first-line carboplatin\/paclitaxel in advanced non-small cell lung cancer (NSCLC): A randomized Phase 1\/2, open-label, controlled study","volume":"24","author":"Pazoles","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"LBA7007","DOI":"10.1200\/jco.2010.28.18_suppl.lba7007","article-title":"A randomized, open-label, phase III trial of NOV-002 in combination with paclitaxel (P) and carboplatin (C) versus paclitaxel and carboplatin alone for the treatment of advanced non-small cell lung cancer (NSCLC)","volume":"28","author":"Fidias","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10549-011-1889-0","article-title":"Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer","volume":"132","author":"Montero","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/15216540701736285","article-title":"Role of the MRP1\/ABCC1 multidrug transporter protein in cancer","volume":"59","author":"Munoz","year":"2007","journal-title":"IUBMB Life"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"30880","DOI":"10.1074\/jbc.R114.609248","article-title":"Multidrug resistance protein 1 (MRP1, ABCC1), a \u201cmultitasking\u201d ATP-binding cassette (ABC) transporter","volume":"289","author":"Cole","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.celrep.2019.01.043","article-title":"A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity","volume":"26","author":"Cao","year":"2019","journal-title":"Cell Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.4161\/auto.22037","article-title":"Glutathione participates in the modulation of starvation-induced autophagy in carcinoma cells","volume":"8","author":"Desideri","year":"2012","journal-title":"Autophagy"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ccell.2019.03.007","article-title":"Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3\u03b2-MCL-1 Axis","volume":"35","author":"Elgendy","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccell.2016.05.016","article-title":"Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance","volume":"30","author":"Pietrocola","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ccell.2016.06.005","article-title":"Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity","volume":"30","author":"Lee","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.1073\/pnas.0708100105","article-title":"Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy","volume":"105","author":"Raffaghello","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrg.2017.47","article-title":"Synthetic lethality and cancer","volume":"18","author":"Bailey","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/iub.1696","article-title":"Synthetic lethality in DNA repair network: A novel avenue in targeted cancer therapy and combination therapeutics","volume":"69","author":"Bhattacharjee","year":"2017","journal-title":"IUBMB Life"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Bhattacharjee, S., and Nandi, S. (2018). Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy. Cancers, 10.","DOI":"10.3390\/cancers10090298"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","article-title":"Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells","volume":"3","author":"Dolma","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/cas.13701","article-title":"Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction","volume":"109","author":"Kerins","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccell.2018.12.009","article-title":"Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers","volume":"35","author":"Ogiwara","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"14844","DOI":"10.1038\/ncomms14844","article-title":"Inhibiting the system xC-\/glutathione axis selectively targets cancers with mutant-p53 accumulation","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e28083","DOI":"10.7554\/eLife.28083","article-title":"Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer","volume":"6","author":"Sayin","year":"2017","journal-title":"eLife"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-18-3527","article-title":"LKB1 and KEAP1\/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma","volume":"79","author":"Sitthideatphaiboon","year":"2019","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1158\/0008-5472.CAN-10-1509","article-title":"Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation","volume":"70","author":"Mandal","year":"2010","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/0008-5472.CAN-18-1938","article-title":"Inhibition of Thioredoxin\/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis","volume":"79","author":"Yan","year":"2019","journal-title":"Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/ars.2016.6841","article-title":"Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer","volume":"27","author":"Roh","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"33832","DOI":"10.18632\/oncotarget.26112","article-title":"Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells","volume":"9","author":"Okazaki","year":"2018","journal-title":"Oncotarget"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3390\/cancers3011285","article-title":"Glutathione in cancer cell death","volume":"3","author":"Ortega","year":"2011","journal-title":"Cancers"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/11\/8\/1926\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:11:32Z","timestamp":1760188292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/11\/8\/1926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,16]]},"references-count":83,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["nu11081926"],"URL":"https:\/\/doi.org\/10.3390\/nu11081926","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,16]]}}}